SCHEMBL3869725

SCHEMBL3869725

C=CCN(CC=C)CCN1CCN(C(C(C)=O)(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.40
▸ ALDH1A1 P00352 5/20 0.40
▸ KMT2A Q03164 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ATM Q13315 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ SIGMAR1 Q99720 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ OPRM1 P35372 3/20 0.35
▸ OPRD1 P41143 5/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ CHRM4 P08173 2/20 0.34
▸ CHRM5 P08912 2/20 0.34
▸ CHRM3 P20309 2/20 0.34
▸ CHRM2 P08172 1/20 0.34
▸ CHRM1 P11229 1/20 0.34
▸ CCR5 P51681 2/20 0.34
▸ OPRK1 P41145 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3860844 0.78 CHRM4 (0.43) KDM4EALDH1A1OPRM1CHRM4CHRM5
SCHEMBL3862213 0.76 KMT2A (0.52) KMT2AMEN1SIGMAR1CHRM3
SCHEMBL5023966 0.75 KCNH2 (0.49) KDM4EALDH1A1OPRM1CHRM4CHRM5
SCHEMBL3862105 0.73 HTR7 (0.43) ALDH1A1KMT2AMEN1SMN1; SMN2SIGMAR1
SCHEMBL5076784 0.71 CACNA2D1 (0.55) —
SCHEMBL5026265 0.68 KMT2A (0.59) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL5026280 0.67 HRH3 (0.44) ALDH1A1KMT2ACHRM1
SCHEMBL7561329 0.67 SIGMAR1 (0.41) SIGMAR1
SCHEMBL15172746 0.67 SIGMAR1 (0.41) SIGMAR1
SCHEMBL5024637 0.66 KDM1A (0.47) KDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670775-A4 PIPERAZINE SUBTITUTED COMPOUNDS USED AS CALCIUM CHANNEL BLOCKERS NEUROMED PHARMACEUTICALS LTD (CA) 2009-04-22 — — EP claimed
JP-2007504174-A — — 2007-03-01 — — JP claimed
EP-1670775-A1 PIPERAZINE SUBTITUTED COMPOUNDS USED AS CALCIUM CHANNEL BLOCKERS Neuromed Pharmaceuticals, Ltd. (CA) 2006-06-21 — — EP claimed
WO-2005021523-A1 PIPERAZINE SUBSTITUTED COMPOUNDS USED AS CALCIUM CHANNEL BLOCKERS NEUROMED TECHNOLOGIES, INC. (CA) 2005-03-10 — — WO claimed
EP-1871372-A1 COMBINATION THERAPY COMPRISING AN N-TYPE CALCIUM CHANNEL BLOCKER FOR THE ALLEVIATION OF PAIN Neuromed Pharmaceuticals, Ltd. (CA) 2008-01-02 — — EP disclosed
WO-2006105670-A1 COMBINATION THERAPY COMPRISING AN N-TYPE CALCIUM CHANNEL BLOCKER FOR THE ALLEVIATION OF PAIN NEUROMED PHARMACEUTICALS LTD. (CA) 2006-10-12 — — WO disclosed
Send feedback